Delivery Order SPE2DB22D2007-SPE2DB25FJ0GM

Award Date 3/28/25
Potential Completion Date 3/31/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,759.27, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distributor Cencora, Inc. The contract is for the delivery of Ropinirole HCL ER 6 mg tablets, a medication commonly used to treat Parkinson's disease. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract, valued at $43,343.82, is for the delivery of Rinvoq ER 15 mg tablets. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) that serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,354.38 firm fixed-price delivery order is for the pharmaceutical product Rytary ER 48.75 mg-195 mg capsules. The contract has an ultimate completion date of December 12, 2023 and was awarded on December 11, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,984.45 firm fixed-price contract is for the delivery of 4557973692 - Eletriptan HBR 40 mg Tablet Units of Use 6s. The contract has an ultimate completion date of August 3, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a $13,519.46 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of 4563084247 RIEGEPANT 75MG ODT 8S medical supplies. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,922,872.47 contract is for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. This award is associated with Amerisourcebergen's larger $999,999,999.00...
This is a $3,137.40 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of pharmaceutical and medical products, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,788.50, is for the delivery of various pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes treatments, neurological medications, pain management pharmaceuticals, hormone treatments, and antibiotics. The contract...
This is a $76,124.58 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of a variety of pharmaceutical products and medical supplies, including medications across therapeutic areas such as diabetes, neurology, pain management, and antibiotics. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract...
This is a $77,249.10 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a variety of pharmaceutical products and medical supplies to support military healthcare programs. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ0GM
    Delivery Order

This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,023.78, is for the supply of Ropinirole HCL ER 6 mg tablets. The contract has a performance period through March 31, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order contract is not designated with a set-aside requirement, indicating open competition.

Generated 6/27/25, 12:24 PM